Related Experiment Videos
Diffuse pulmonary ossification detected by bone scanning with Tc-99m hydroxymethylene diphosphate.
Clinical Nuclear Medicine
|October 1, 1984
Summary
Diffuse pulmonary ossification, a rare lung condition, was found to be associated with Placidyl use in this case. This finding adds to the known causes of heterotropic bone formation in the lungs.
Area of Science:
- Pulmonology
- Pathology
- Pharmacology
Background:
- Diffuse pulmonary ossification (DPO) is characterized by heterotropic bone formation in lung tissue.
- DPO is a rare condition with diverse established associations.
Observation:
- This report details a unique case of DPO.
- The patient's presentation was linked to the use of Placidyl.
Findings:
- The case study identifies a potential novel association between Placidyl and the development of diffuse pulmonary ossification.
- This finding expands the known iatrogenic causes of DPO.
Implications:
- Clinicians should consider Placidyl as a potential contributing factor in patients diagnosed with DPO.
- Further research is warranted to elucidate the mechanism linking Placidyl to pulmonary ossification.